JPRN-UMIN000008174已完成未知
Phase II study of S-1 for relapsed or refractory thymoma or thymic carcinoma - S-1 for Relapsed or Refractory Thymoma/Thymic Cancer
orth Japan Lung Cancer Group0 个研究点目标入组 40 人开始时间: 2012年6月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100Not applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Serious uncontrolled infections or body temperature higher than 38 degree centigrade 2. Continuous administration of an oral steroid or an immunosuppressive agent 3. With severe concurrent disease 4. Symptomatic brain metastasis 5. With malignant pleural, peritoneal effusion requiring drainage or pericardial effusion 6. With severe drug allergies 7. Contraindication with S-1 8. Previous treatment with fluoropyrimidines such as S-1, UFT 9. Current use of flucytosine 10. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray 11. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 12. Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
已完成
不适用
A phase II trial of S-1 monotherapy for relapsed thymoma and thymic carcinoma: Okayama Lung Cancer Study Group Trial (OLCSG 1302)Thymoma/Thymic carcinomaJPRN-UMIN000009845Okayama Lung Cancer Study Group(OLCSG)30
已完成
不适用
Phase II trial of S-1 therapy for advanced or recurrent esophageal cancer resistant or intolerable existing treatmentsesophageal cancerJPRN-UMIN000023736Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine50
Unknown
1 期
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)Multiple Myeloma in RelapseMantle Cell Lymphoma in RelapseDiffuse Large B Cell Lymphoma in RelapseOther B Cell Lymphoma in RelapseMultiple MyelomaPlasma Cell LeukemiaNCT01435720Senesco Technologies, Inc.15
已完成
2 期
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.on-small cell lung cancerJPRN-UMIN000000817agasaki Thoracic Oncology Group32
已完成
2 期
Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLCon-small cell lung cancerJPRN-UMIN000002035Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School40